About Kailos
Kailos is a company based in Huntsville (United States) founded in 2010 was acquired by HealthOme in June 2023. Kailos has raised $3.9 million across 4 funding rounds from investors including NIH, healthŌme and In-Q-Tel. The company has 10 employees as of December 31, 2022. Kailos offers products and services including Precision Medicine Sequencing Panels, TargetRich Enrichment Technology, and Reagents and Services. Kailos operates in a competitive market with competitors including Helix, Color, Veritas Genetics, Counsyl and GreenLight Biosciences, among others.
- Headquarter Huntsville, United States
- Employees 10 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Kailos Genetics, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kailos
Kailos offers a comprehensive portfolio of products and services, including Precision Medicine Sequencing Panels, TargetRich Enrichment Technology, and Reagents and Services.
Customizable panels for integrating into laboratory workflows.
Technology for enhanced genetic sequencing and analysis.
Complete kits for genetic research and data analysis.
People of Kailos
Unlock access to complete
Unlock access to complete
Funding Insights of Kailos
Kailos has successfully raised a total of $3.9M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $2 million completed in April 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Kailos
Kailos has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, healthŌme and In-Q-Tel.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm
|
Locked | Locked | Locked | |
|
Drug discovery services are provided to the biopharma sector.
|
Locked | Locked | Locked | |
|
Genetic testing and support services for cancer risks are provided.
|
Locked | Locked | Locked |
Investor details for Kailos
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Kailos
Investment portfolio details for Kailos
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Kailos
Detailed financials for Kailos
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Kailos Comparisons
Peer comparison for Kailos
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Kailos
Kailos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Helix, Color, Veritas Genetics, Counsyl and GreenLight Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Genomic database for clinical research is provided.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Genetic testing products for health risks and traits are offered.
|
|
| Locked | Locked | Locked |
DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening
|
|
| Locked | Locked | Locked |
RNA-based platform for life sciences is developed by GreenLight Biosciences.
|
|
| Locked | Locked | Locked |
Provider of direct-to-consumer genetic testing.
|
Detailed competitors of Kailos
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Kailos
Complete news archive for Kailos
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Kailos
Kailos was founded in 2010 and raised its 1st funding round 1 year after it was founded.
Kailos is headquartered in Huntsville, United States. It is registered at Huntsville, Alabama, United States.
Kailos is a funded company, having raised a total of $3.9M across 4 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Kailos is 10.
Founded in 2010 and headquartered in Huntsville, United States, operations in the biotechnology sector are focused on consumer genetic testing. Clinical-grade assays and next-generation sequencing are utilized to deliver actionable genetic insights. Services encompass cancer testing, pharmacogenetic analysis, and research support, enabling personalized health information for individuals and studies.
Kailos's top competitors include GreenLight Biosciences, Helix and Veritas Genetics.
Kailos offers Precision Medicine Sequencing Panels, TargetRich Enrichment Technology, and Reagents and Services.